InfuSystem Holdings, Inc. (INFU) |
| 9.99 0.26 (2.67%) 04-14 16:00 |
| Open: | 9.805 |
| High: | 9.99 |
| Low: | 9.74 |
| Volume: | 125,486 |
| Market Cap: | 203(M) |
| PE Ratio: | 32.23 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 11.76 |
| Resistance 1: | 10.07 |
| Pivot price: | 9.52 |
| Support 1: | 9.24 |
| Support 2: | 8.72 |
| 52w High: | 11.04 |
| 52w Low: | 4.66 |
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Sat, 11 Apr 2026
InfuSystem: Expecting Strong Stock Gains In 2026 (NYSE:INFU) - Seeking Alpha
Fri, 10 Apr 2026
[DEF 14A] InfuSystem Holdings, Inc Definitive Proxy Statement - Stock Titan
Thu, 19 Mar 2026
InfuSystem Holdings appoints Grant Thornton as new auditor, replacing Deloitte - Investing.com
Tue, 17 Mar 2026
InfuSystem To Present At 38th Annual ROTH Conference - The Globe and Mail
Mon, 16 Mar 2026
InfuSystem to Participate at 38th Annual ROTH Conference on March 23, 2026 - Yahoo Finance
Tue, 03 Mar 2026
InfuSystem stock gains after CFO buys shares - Investing.com
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |